In Veritas Medical Diagnostics, Inc.
IVME · OTC
1/31/2008 | 10/31/2007 | 7/31/2007 | 4/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Income | $0 | $0 | $1 | $0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | -$1 | -$1 | -$2 | -$1 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS | -0.01 | -0.011 | -0.019 | -0.012 |
| % Growth | 5.5% | 43.6% | -68% | – |
| EPS Diluted | -0.01 | -0.011 | -0.019 | -0.012 |
| Weighted Avg Shares Out | 60 | 60 | 60 | 60 |
| Weighted Avg Shares Out Dil | 60 | 60 | 60 | 60 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | – | – |